Go Pro
→ A councilman backed AI — then 13 bullets hit his front door (From Stansberry Research) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
$1.45
+2.1%		$1.48
$1.25
▼
$3.11
$9.44M0.37,440 shs1,863 shs
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
$3.53
-19.8%		$3.88
$2.72
▼
$5.01
$35.48M0.4715,963 shs11,067 shs
DocGo Inc. stock logo
DCGO
DocGo
$0.36
+0.4%		$0.52
$0.35
▼
$1.65
$35.53M0.94728,330 shs462,362 shs
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
$0.45
-5.4%		$0.45
$0.16
▼
$2.75
$10.27M2.04462,511 shs425,186 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
+2.11%0.00%-3.97%-1.36%-42.69%
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
-19.77%-19.77%-22.59%-9.49%-27.22%
DocGo Inc. stock logo
DCGO
DocGo
+0.45%-3.84%-16.96%-28.79%-75.12%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
-5.36%+9.88%+6.75%+29.83%-79.98%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
$1.45
+2.1%		$1.48
$1.25
▼
$3.11
$9.44M0.37,440 shs1,863 shs
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
$3.53
-19.8%		$3.88
$2.72
▼
$5.01
$35.48M0.4715,963 shs11,067 shs
DocGo Inc. stock logo
DCGO
DocGo
$0.36
+0.4%		$0.52
$0.35
▼
$1.65
$35.53M0.94728,330 shs462,362 shs
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
$0.45
-5.4%		$0.45
$0.16
▼
$2.75
$10.27M2.04462,511 shs425,186 shs
(Almost) Everything You Need To Know About The EV Market Cover
(Almost) Everything You Need To Know About The EV Market

Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
+2.11%0.00%-3.97%-1.36%-42.69%
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
-19.77%-19.77%-22.59%-9.49%-27.22%
DocGo Inc. stock logo
DCGO
DocGo
+0.45%-3.84%-16.96%-28.79%-75.12%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
-5.36%+9.88%+6.75%+29.83%-79.98%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
0.00
N/AN/AN/A
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
2.00
HoldN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
2.33
Hold$2.38558.26% Upside
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest AMS, DCGO, CCEL, and MGRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/14/2026
DocGo Inc. stock logo
DCGO
DocGo
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
8/18/2026
DocGo Inc. stock logo
DCGO
DocGo
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingHold$1.00
8/18/2026
DocGo Inc. stock logo
DCGO
DocGo
Needham & Company LLC logo
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$3.00
6/24/2026
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 9/22/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
$28.08M0.34$0.67 per share2.17$4.23 per share0.34
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
$31.57M0.90N/AN/A($2.31) per share-1.53
DocGo Inc. stock logo
DCGO
DocGo
$322.20M0.11$0.06 per share6.49$1.28 per share0.28
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
$460K21.12N/AN/A$0.93 per share0.48
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
-$1.55M$0.60N/AN/AN/A-5.83%-6.52%-3.19%11/12/2026 (Estimated)
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
-$2.43M-$1.06N/AN/AN/A-7.92%N/A-4.00%N/A
DocGo Inc. stock logo
DCGO
DocGo
-$182.40M-$1.96N/AN/AN/A-65.29%-40.42%-24.81%11/9/2026 (Estimated)
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
-$20.64M-$1.01N/AN/AN/A-4,794.60%-96.39%-89.60%N/A

Latest AMS, DCGO, CCEL, and MGRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/17/2026Q2 2026
DocGo Inc. stock logo
DCGO
DocGo
-$0.0975-$0.16-$0.0625-$0.16$75.35 million$73.42 million
8/13/2026Q2 2026
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
-$0.02-$0.07-$0.05-$0.07$7.56 million$8.43 million
8/13/2026Q2 2026
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/A-$0.09N/A-$0.09N/A$0.08 million
7/15/2026Q2 2026
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
N/A$0.07N/A$0.07N/A$7.78 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
N/AN/AN/AN/AN/A
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
N/AN/AN/AN/AN/A
DocGo Inc. stock logo
DCGO
DocGo
N/AN/AN/AN/AN/A
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
N/A
0.77
0.77
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
N/A
0.71
0.69
DocGo Inc. stock logo
DCGO
DocGo
N/A
1.66
1.66
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
N/A
0.18
0.18

Institutional Ownership

CompanyInstitutional Ownership
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
23.16%
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
10.44%
DocGo Inc. stock logo
DCGO
DocGo
56.44%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
56.72%

Insider Ownership

CompanyInsider Ownership
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
25.80%
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
38.59%
DocGo Inc. stock logo
DCGO
DocGo
5.10%
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
16.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
American Shared Hospital Services stock logo
AMS
American Shared Hospital Services
106.65 million4.93 millionNot Optionable
Cryo-Cell International Inc. stock logo
CCEL
Cryo-Cell International
768.06 million4.95 millionNot Optionable
DocGo Inc. stock logo
DCGO
DocGo
3,56898.93 million93.88 millionOptionable
Mangoceuticals, Inc. stock logo
MGRX
Mangoceuticals
321.57 million18.12 millionNot Optionable

Recent News About These Companies

Mangoceuticals (NASDAQ:MGRX) Trading Up 4.6% - What's Next?
September 12, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31018028
Mangoceuticals Terminates Planned Business Combination with Nuclea
August 21, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mangoceuticals-terminates-planned-business-combination-with-nuclea?utm_source=marketbeat.com&utm_medium=referral
MGRX Stock Alert: Halper Sadeh LLC is Investigating Whether Mangoceuticals, Inc. is Obtaining a Fair Price for its Shareholders
August 17, 2026  |  businesswire.comhttps://www.businesswire.com/news/home/20260817547736/en/MGRX-Stock-Alert-Halper-Sadeh-LLC-is-Investigating-Whether-Mangoceuticals-Inc.-is-Obtaining-a-Fair-Price-for-its-Shareholders/
Mangoceuticals Inc.’s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy’s Advanced Nuclear Technology Assets
August 13, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-inc-s-merger-partner-nuclea-energy-inc-enters-into-definitive-agreement-to-acquire-moltex-energy-s-advanced-nuclear-technology-assets-1036455781
Mangoceuticals Inc.'s Merger Partner, Nuclea Energy, Inc., Enters into Definitive Agreement to Acquire Moltex Energy's Advanced Nuclear Technology Assets
August 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/13/3344935/0/en/mangoceuticals-inc-s-merger-partner-nuclea-energy-inc-enters-into-definitive-agreement-to-acquire-moltex-energy-s-advanced-nuclear-technology-assets.html
Nuclea Energy, Enters into Definitive Agreement to Acquire Moltex Energy's Advanced Nuclear Technology Assets
August 13, 2026  |  newsfilecorp.comN
Mangoceuticals’ Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure
August 6, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/mangoceuticals-merger-partner-nuclea-energy-inc-signs-mou-with-new-mining-co-to-advance-behind-the-meter-modular-reactor-deployment-for-high-density-computing-infrastructure-1036419038
Mangoceuticals (MGRX) stock jumps over 49% after hours: Here's why
August 6, 2026  |  msn.comhttps://www.msn.com/en-us/money/news/mangoceuticals-mgrx-stock-jumps-over-49-after-hours-heres-why/ar-AA29uZrm
Mangoceuticals' Merger Partner, Nuclea Energy Inc., Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure
August 6, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/06/3340117/0/en/mangoceuticals-merger-partner-nuclea-energy-inc-signs-mou-with-new-mining-co-to-advance-behind-the-meter-modular-reactor-deployment-for-high-density-computing-infrastructure.html
Nuclea Energy Signs MOU with New Mining Co. to Advance Behind-the-Meter Modular Reactor Deployment for High-Density Computing Infrastructure
August 6, 2026  |  newsfilecorp.comN
Mangoceuticals, Inc.: Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination
August 5, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-08/69220370-mangoceuticals-inc-mangoceuticals-granted-180-day-extension-by-nasdaq-to-regain-compliance-with-minimum-bid-price-requirement-and-comments-on-nucle-399.htm
Mangoceuticals’ Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development
August 5, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/energy/articles/mangoceuticals-merger-partner-nuclea-energy-200500063.html
Nuclea Energy USA Inc. Announces MOU with Utah Office of Energy Development
August 5, 2026  |  newsfilecorp.comN
Mangoceuticals' Merger Partner, Nuclea Energy (“Nuclea”), Executes MOU with Utah Office of Energy Development
August 5, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/05/3339719/0/en/mangoceuticals-merger-partner-nuclea-energy-nuclea-executes-mou-with-utah-office-of-energy-development.html
Mangoceuticals Wins Nasdaq Extension Amid Nuclea Deal Progress
August 4, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/mangoceuticals-wins-nasdaq-extension-amid-nuclea-deal-progress?utm_source=marketbeat.com&utm_medium=referral
Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination
August 4, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/04/3338795/0/en/mangoceuticals-granted-180-day-extension-by-nasdaq-to-regain-compliance-with-minimum-bid-price-requirement-and-comments-on-nuclea-energy-business-combination.html
MGRX surges after Nuclea Energy reverse-merger deal reshapes company story
July 31, 2026  |  quiverquant.comQ
Mangoceuticals (MGRX) stock jumps 138% after hours on nuclear reactor deal: Here's why it is trending
July 31, 2026  |  msn.comhttps://www.msn.com/en-us/health/other/mangoceuticals-mgrx-stock-jumps-138-after-hours-on-nuclear-reactor-deal-heres-why-it-is-trending/ar-AA2966QZ
Mangoceuticals, Inc.: Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology
July 30, 2026  |  finanznachrichten.dehttps://www.finanznachrichten.de/nachrichten-2026-07/69170960-mangoceuticals-inc-mangoceuticals-announces-business-combination-agreement-with-nuclea-energy-inc-to-advance-next-generation-nuclear-microreactor-399.htm
Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor
July 30, 2026  |  newsfilecorp.comN

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
NVIDIA logo over a computer chip, server racks, and an upward-trending green stock price chart.
NVIDIA’s Blockbuster Quarter May Still Undersell How Big the AI Buildout Is
By Thomas Hughes | August 27, 2026
Shoppers browse folded and hanging clothing in a retail apparel store with shelves and racks displayed.
3 Retail Stocks to Watch After a Big Consumer Earnings Week
By Dan Schmidt | August 29, 2026
Williams Sonoma circular logo sign on a wall surrounded by kitchenware, bowls, a pepper mill, and cutting board.
Williams-Sonoma’s Quarter Gave Bulls More Than Just a Beat-and-Raise
By Thomas Hughes | August 26, 2026
Large haul trucks travel a winding road through an open-pit mine at sunrise or sunset.
Bond Yields Are Pressuring Gold, But Miners May Tell a Different Story
By Jeffrey Neal Johnson | September 8, 2026
Palo Alto Networks logo displayed amid a server data center and a digital globe with network connections.
Palo Alto Networks Is Expensive—But Its Growth Is Accelerating
By Thomas Hughes | September 3, 2026
American Shared Hospital Services stock logo

American Shared Hospital Services NYSEAMERICAN:AMS

$1.45 +0.03 (+2.11%)
As of 09/21/2026 04:10 PM Eastern

American Shared Hospital Services provides stereotactic radiosurgery and advanced radiation therapy equipment. It operates in two segments, Medical Equipment Leasing, and Retail. The company offers radiosurgery equipment for the Gamma Knife stereotactic radiosurgery, a non-invasive procedure to treat malignant and benign brain tumors, and arteriovenous malformations, as well as for trigeminal neuralgia. It also provides financing services for Leksell Gamma Knife units; and leases medical equipment. In addition, the company offers proton beam radiation therapy services in Orlando, Florida and Long Beach, California, as well as offers planning, installation, reimbursement, and marketing support services to its customers. The company markets its solutions to cancer treatment centers, hospitals, and cancer networks worldwide. American Shared Hospital Services was founded in 1980 and is based in San Francisco, California.

Cryo-Cell International stock logo

Cryo-Cell International NYSEAMERICAN:CCEL

$3.53 -0.87 (-19.77%)
As of 09/21/2026 04:10 PM Eastern

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

DocGo stock logo

DocGo NASDAQ:DCGO

$0.36 +0.00 (+0.45%)
As of 09/21/2026 04:00 PM Eastern

DocGo Inc. provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services. It also offers mobile health services through its platform that are performed at home, offices, and other locations; event services, which include on-site healthcare support at sporting events and concerts; and total care management solutions comprising healthcare services and ancillary services, such as shelter. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

Mangoceuticals stock logo

Mangoceuticals NASDAQ:MGRX

$0.45 -0.03 (-5.36%)
As of 09/21/2026 04:00 PM Eastern

Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas